Robin Li
Founder

BioMap provides a platform that integrates high‑throughput spatial omics and advanced imaging to create detailed, spatially resolved maps of gene expression, protein levels, and other molecular markers within intact tissue sections. Its cloud‑based system offers automated image alignment, interactive multi‑omic visualizations, and analytics tools that let researchers query, compare, and export data for downstream bioinformatics workflows.
Raised to date
$100MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Founder
There is limited access to comprehensive, spatially resolved biological data that integrates molecular profiling with tissue architecture, hindering research and diagnostic insights.
BioMap offers a platform that combines high-throughput spatial omics technologies with advanced imaging to generate detailed maps of biomolecular distribution within tissue samples. The system captures gene expression, protein levels, and other molecular markers while preserving spatial context, enabling researchers to visualize and analyze complex biological processes in situ. Integrated analytics tools allow users to query, compare, and interpret spatial patterns across multiple samples, supporting hypothesis generation and validation. Data can be exported in standard formats for downstream bioinformatics pipelines or incorporated into collaborative research portals.
Primary users are academic and industry researchers in genomics, pathology, and drug discovery who require spatially resolved molecular data for tissue-based studies.